Andy Tran

Postdoctoral Research Associate

Institute for Infection and Immunity, St George’s University of London

VALIDATE Role:

Network Associate

Research Keywords:
TB, Animal Models, Antibodies, IgA, Vaccines, Mucosal

Biography:

Andy Tran is a postdoctoral research associate at St George’s University of London, where he has a keen focus on the development of new treatments and vaccines for tuberculosis (TB). He completed his PhD in 2020 on the role of antibodies in tuberculosis and spent a year working on a diagnostic assay development for TiKa Diagnostics Ltd, a St George's University of London start-up company. Andy has since returned to the Prof. Rajko Reljic lab where he has been involved as principle and co-investigator in numerous projects aimed at tackling TB, including developing novel self-adjuvanting vaccine candidates, human alveolar models and discovering new TB biologics.

Key Publications:

Hyde K, Sultana K, Tran AC, Bileckaja N, Donald CL, Kohl A, Stanton RJ, Strang BL, Limited replication of human cytomegalovirus in a trophoblast cell line, Journal of General Virology
Tran AC, Diogo G et al Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ, Frontiers in Immunology (2020), 10.3389/fimmu.2020.582833
Diogo G, Hart P, Copland A, Kim MY, Tran AC et al, Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG, Frontiers in Immunology (2019), 10.3389/fimmu.2019.01349
Tran AC, Kim MY, Reljic R, Emerging themes for the role of antibodies in tuberculosis, Immune Network (2019), 10.4110/in.2019.19.e24
Kuczkowska K, Copland A, Øverland L, Mathiesen G, Tran AC et al, Inactivated Lactobacillus plantarum Carrying a Surface-Displayed Ag85B-ESAT-6 Fusion Antigen as a Booster Vaccine against Mycobacterium tuberculosis Infection, Frontiers in Immunology (2019) 10.3389/fimmu.2019.01588
Copland A, Diogo G, Hart P, Harris S, Tran AC et al, Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin, Frontiers in Immunology (2018), 10.3389/fimmu.2018.00346

Web links of interest: